SIGA

Healthcare Drug Manufacturers - Specialty & Generic

SIGA Technologies, Inc.

$3.29

-0.00 -0.05% today

Price History

Not enough data

Key Stats

Market Cap

236.39M

Avg Volume

726,704

EPS

-$0.04

52W High

$8.55

52W Low

$2.83

Div. Yield

0.0%

Valuation

Forward P/E

3.05

P/B Ratio

1.43

P/S Ratio

4.41

EV/EBITDA

-11.30

EV/Revenue

2.22

PEG Ratio

3.37

Margins

Gross Margin 16.3%

Operating Margin 33.9%

Net Margin (5.2%)

EBITDA Margin (19.7%)

Growth & Returns

Revenue Growth (YoY)

(49.5%)

Earnings Growth (YoY)

(65.3%)

Earnings Growth (QoQ)

(64.9%)

Return on Equity

(1.5%)

Return on Assets

(3.4%)

Liquidity & Leverage

Current Ratio

21.72

Quick Ratio

15.90

Debt / Equity

0.00

Total Cash

117.58M

Total Debt

439,397

About

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.